| Application no. and date | 20801237.7 (espacenet) (Federated) (European Patent Register), 20201104 | | Patent/reg. no. and date | DK/EP 4054537, 20230607 | | Publication date | 20220914 | | Priority no. and date | SE 1951255, 20191104 | | EP pub. no. and date |
EP 4054537 20220914 | | Effective date | | | Applicant/owner | Cinclus Pharma Holding AB (publ), Kungsbron 1, Level 3, Elevator G
111 22 Stockholm, SE | | Applicant ref. no. | | | Inventor | ANDERSSON, Kjell, Odonvägen 3
437 31 Lindome, SE,
SPRINGFELTER, Mattias, Luftgränd 11
192 74 Sollentuna, SE,
YOUSEF, Gabriella, Humblegatan 28B
172 39 Sundbyberg, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61K 9/20 (2006.01) , A61P 1/04 (2006.01) | | Title | ORAL FORMULATION OF X842 | | Int. application no. | EP2020080877 | | Int. publication no. | WO2021089580 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
